A clinical trial in Dallas will test new technology that could help infants overcome withdrawal from exposure to opioids while in the womb.
Spark Biomedical created the FDA-approved Sparrow Therapy System. It’s essentially an earpiece that sends mild electrical pulses to the brain to help alleviate the withdrawal symptoms that patients go through while they’re detoxing, like insomnia, tremors, chills and sweating, bone pain, mood swings, and more.
The Medical University of South Carolina and UT Southwestern Medical Center join Spark Biomedical in Phase II clinical trial.
